A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression
AUTOR(ES)
Ito, Kazuhiro
FONTE
National Academy of Sciences
RESUMO
The molecular mechanism for the anti-inflammatory action of theophylline is currently unknown, but low-dose theophylline is an effective add-on therapy to corticosteroids in controlling asthma. Corticosteroids act, at least in part, by recruitment of histone deacetylases (HDACs) to the site of active inflammatory gene transcription. They thereby inhibit the acetylation of core histones that is necessary for inflammatory gene transcription. We show both in vitro and in vivo that low-dose theophylline enhances HDAC activity in epithelial cells and macrophages. This increased HDAC activity is then available for corticosteroid recruitment and predicts a cooperative interaction between corticosteroids and theophylline. This mechanism occurs at therapeutic concentrations of theophylline and is dissociated from phosphodiesterase inhibition (the mechanism of bronchodilation) or the blockade of adenosine receptors, which are partially responsible for its side effects. Thus we have shown that low-dose theophylline exerts an anti-asthma effect through increasing activation of HDAC which is subsequently recruited by corticosteroids to suppress inflammatory genes.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=124399Documentos Relacionados
- Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity
- A non-isotopic assay for histone deacetylase activity.
- Autoregulation of Mouse Histone Deacetylase 1 Expression
- Histone Deacetylase Activity Represses Gamma Interferon-Inducible HLA-DR Gene Expression following the Establishment of a DNase I-Hypersensitive Chromatin Conformation
- Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation